WO2001092632A1 - Fiber product having antibacterial and deodorant function - Google Patents
Fiber product having antibacterial and deodorant function Download PDFInfo
- Publication number
- WO2001092632A1 WO2001092632A1 PCT/JP2001/004493 JP0104493W WO0192632A1 WO 2001092632 A1 WO2001092632 A1 WO 2001092632A1 JP 0104493 W JP0104493 W JP 0104493W WO 0192632 A1 WO0192632 A1 WO 0192632A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medical
- cellulose
- amino acid
- fiber
- sanitary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/10—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
- D06M13/224—Esters of carboxylic acids; Esters of carbonic acid
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/325—Amines
- D06M13/342—Amino-carboxylic acids; Betaines; Aminosulfonic acids; Sulfo-betaines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
- D06M2101/04—Vegetal fibres
- D06M2101/06—Vegetal fibres cellulosic
Definitions
- the present invention relates to a textile product having excellent antibacterial properties, deodorant properties, durability against washing, and safety. More specifically, it contains a fiber product containing a basic amino acid cellulose partial ester and Z or a salt thereof, or a cellulose fiber obtained by contacting the cellulose fiber with a basic amino acid ester and then heating. Related to textile products.
- the present invention also relates to the use of textile products having excellent antibacterial properties and safety as medical or hygiene products.
- In medical or hygiene products such as medical sheets, medical towels, medical drapes, surgeon gowns, patient clothing, medical caps, medical aprons, and medical covers, these products can It is an environment in which microorganisms can be easily propagated by contacting mucous membranes or wounds and absorbing secreted, exuded or excreted liquid from the living body during use, and extremely contaminated with bacteria during surgery. Dislike used in medical settings Therefore, antibacterial activity is considered to be one of the important functions from the viewpoint of infectious disease prevention.
- JP-A-6-1231 and JP-A-63-249701 disclose that copper is antibacterial. Socks used as agents are disclosed.
- Japanese Patent Application Laid-Open No. 3-249201 discloses a sock which has been subjected to antibacterial deodorizing treatment using a combination of a polyvalent metal and a quaternary ammonium salt.
- Japanese Patent Application Laid-Open No. 5-49682 discloses a sock using aluminum oxide, silicon oxide and magnesium oxide as antibacterial agents.
- Japanese Unexamined Patent Publication No. Hei 6-2878111 discloses a raw yarn for socks using a soluble glass containing silver oxide as an antibacterial agent.
- Japanese Patent Application Laid-Open No. Hei 4-2345 discloses a disposable diaper containing benzalkonium chloride as an antibacterial agent.
- Japanese Unexamined Patent Publication No. 5-212904 discloses a sanitary article in which silver is supported on a strong thione exchange resin composed of a polystyrene resin having a sulfonate group introduced therein as an antibacterial agent.
- Japanese Unexamined Patent Publication No. Hei 9-1990 discloses a body fluid-absorbing article containing chlorhexidine hydrochloride or domifamine bromide as an antibacterial agent.
- 9-10882 Discloses a sanitary and sanitary product containing phytontide included in cyclodextrin as an antibacterial agent.
- Japanese Patent Application Laid-Open No. 11-18995 discloses a sanitary article having carboxymethylcellulose carrying silver as an antibacterial agent.
- Japanese Patent Application Laid-Open No. H11-2012 discloses an antibacterial sheet containing a plant-derived water-soluble extract containing a rosinamine compound and a sanitary article comprising the same.
- each of these products contains a drug or metal having antibacterial activity in a part of the product, and the content of these antibacterial components is mixed. It is thought that it may cause allergies due to dissolution due to the secretion, exudation or excretion from the living body due to liquids that adhere to or adhere to the skin, or fall off due to friction with the skin, mucous membranes or wounds.
- An object of the present invention antibacterial, deodorant, durability to laundering, another object of the c the present invention is to provide a textile product to solve one problem at least as excellent as the safety, health or hygiene
- An object of the present invention is to provide a fiber product excellent in antibacterial properties and safety suitable as a product.
- the present inventors have found that the above problems can be solved by using a specific cellulose ester, or by using a specific treated cellulose fiber or a fiber product comprising the cellulose fiber. Completed.
- the present invention is a fiber product comprising a basic amino acid cellulose partial ester and / or a salt thereof.
- the present invention provides a fiber product comprising a cellulose fiber obtained by contacting the cellulose fiber with a basic amino acid ester and then performing a heat treatment, and further comprising a step of blending the cellulose fiber with other fibers. , Mixed weave Or a twisted fiber product.
- the present invention also contemplates the use of fibrous products composed of a basic amino acid cellulose partial ester having antimicrobial properties per se and / or a salt thereof in medical or sanitary products or parts thereof. That is, the present invention relates to the use of a fiber product comprising a basic cellulose amino acid partial ester and / or a salt thereof as a medical or sanitary product.
- the basic amino acid cellulose partial ester has a structure in which the carboxyl group of the basic amino acid and the hydroxyl group of the cellulose are covalently bonded (ester bond), and is less likely to fall off due to water, sweat, etc., and thus has durability against washing. High in nature. Also, when used as medical or hygiene products, the likelihood of secretion, exudation from the living body, elution by exuded liquid, or detachment due to friction with skin, mucous membranes or wounds is low. In addition, since the component that is removed even when the ester bond is cleaved is an amino acid that is harmless to the living body, its safety is extremely high.
- the basic amino acid cellulose partial ester and / or a salt thereof used in the present invention has a structure in which at least one of the hydroxyl groups in the cellulose molecule is reesterified with a basic amino acid.
- the basic amino acid may be a mixture of several kinds, and those having a degree of ester substitution of 0.001 to 3 are used.
- the basic amino acid portion is lysine, arginine, orditin or histidine residue, and lysine cellulose partial ester, arginine cellulose partial ester, It becomes orbitin cellulose partial ester and histidine cellulose partial ester.
- the basic amino acid may be a mixed amino acid.
- Basic amino acid cellulose partial ester used in the present invention or A fiber product characterized by containing its salt can be manufactured as follows. That is, first, a cellulose fiber or a fiber product composed of the cellulose fiber is brought into contact with a treating agent solution containing a basic amino acid ester, and then appropriately drained and dried. Next, a heat treatment is performed, and then a post-treatment such as washing is performed to remove unreacted basic amino acid ester and the like.
- the cellulose used here may be pre-treated with cotton or the like by a usual cotton method.
- the basic amino acid residue bonded to the cellulose fiber can be converted into an arbitrary acid salt.
- Salt types include, for example, organic or hydrochloride salts such as acetate, lactate, malate, tartrate, succinate, citrate, benzoate, pyrrolidone carboxylate, sulfate, Inorganic acid salts such as phosphates or Lewis acid salts such as, for example, zinc chloride.
- organic or hydrochloride salts such as acetate, lactate, malate, tartrate, succinate, citrate, benzoate, pyrrolidone carboxylate, sulfate, Inorganic acid salts such as phosphates or Lewis acid salts such as, for example, zinc chloride.
- the cellulose fiber obtained by the above method is mixed with other fibers, for example, synthetic fibers such as nylon, polyester, and acrylic, or natural fibers such as wool, silk, and the like, in accordance with the usual method, and then mixed or woven or twisted.
- synthetic fibers such as nylon, polyester, and acrylic
- natural fibers such as wool, silk, and the like
- the cellulose fiber obtained by the above method may be in any form of raw cotton and raw yarn, raw fabric or after sewing.
- a solution in which a lower alkyl ester having 1 to 6 carbon atoms represented by a basic amino acid ester, preferably a methyl ester is dissolved in water, alcohol or a mixture thereof is used.
- the basic amino acid ester is a salt such as hydrochloric acid or sulfuric acid, it may be neutralized with a basic amino acid ester of 10 to 20 OmoI% hydroxide as needed.
- the content ratio of the basic amino acid ester in the treating agent solution is arbitrary as long as it dissolves and disperses. Cellulose is added to this treating solution. After immersing the fiber and draining as needed, air-dry or heat-dry as appropriate.
- the term "textile product” is a generic term for woven fabric, felt, non-woven fabric, mat, and the like.
- the form or form of processing is listed here. If those of the final product prior stage after sewing, Shiagere these final products go further appropriate processing.
- a fiber product containing such a basic amino acid cellulose partial ester and / or a salt thereof as a component is preferably used as a medical or hygiene product.
- a basic ester of cellulose amino acid and / or a salt thereof in the form of a cloth or a non-woven fabric should not be disposed on at least a part of the product, particularly on the contact surface with the skin, mucous membrane or wound. Any other structure may be used, and the other parts may adopt a conventionally known structure.
- Disposable diapers, incontinence pads, sanitary napkins, sanitary tampon, pante Medical or hygiene products such as medical sheets, sweat pads, breast milk pads, medical tampons, cotton swabs, bandages, surgical dressings, etc. that have the purpose of absorbing fluids exuded, exuded or drained from the body, such as
- Medical or hygiene products such as medical sheets, sweat pads, breast milk pads, medical tampons, cotton swabs, bandages, surgical dressings, etc. that have the purpose of absorbing fluids exuded, exuded or drained from the body, such as
- an absorbent or a part of the absorber provided with the basic amino acid cellulose partial ester and the Z or its salt may be used.
- the form does not necessarily need to be a cloth or a nonwoven fabric, but may be a fibrous or powdery form.
- Test example 1 Determination of amino acid binding amount
- Example 2 Approximately 0.5 g of a piece was prepared from the sock manufactured in Example 1, and dried overnight at 50 ° C. in a vacuum desiccator containing phosphorus pentoxide as a desiccant. After accurately weighing this sample, it was stirred in 0.5 N sodium hydroxide (5 OmI) at room temperature for 18 hours to carry out alkali hydrolysis. After filtering off the fibers, L-lysine was quantified using an amino acid analyzer (Hitachi L-8500). When the amount of lysine-lysine bound per 1 g of sample was calculated from the results, It was 106 mm o I.
- a square section of about 18 mm on a side was made from the sock manufactured in Example 1, and an antibacterial activity test was conducted according to the unified test method by the Council for Evaluation of New Functions of Textile Products.
- Staphylococcus aureus (S taphylococcusaureus ATCC 6538 P) was used as a test bacterium. After inoculation with high-pressure steam sterilization analyte in bacteria suspended in N utrient B roth medium (about 2. 6 x 1 0 4), was carried out for 1 8 h culture at 3 7 ° C, the viable count It was measured.
- the socks were washed five times according to the procedure described in “rj ISL 0127, 103”, inoculated and cultured in the same manner, and the viable cell count was measured. Note that a nylon standard white cloth was used as the standard white cloth.
- the bacteriostatic activity value and the bactericidal activity value were calculated according to the following equations described in JIS L1902: 19998.
- M a is the common logarithm of the viable cell count immediately after inoculation of non-processed sample (average of three samples)
- M b is a non-processed sample 18
- M. Represents common logarithm of viable cell count (average of 3 samples) of processed sample after 18 hours culture. Table 1 shows the results of the antibacterial activity test.
- the values of the socks of Example 1 satisfy the standard values for antibacterial and deodorant treatment set by the Textile Product New Function Evaluation Council. From these results, it was confirmed that the socks produced in Example 1 exhibited sufficient antibacterial properties and also had washing durability.
- Test example 3 Wear test
- Three male panels wear untreated socks on one leg and the socks manufactured in Example 1 on the other leg for 8 hours each, and then have three levels of odor, sweat absorption, and feeling of wearing.
- the evaluation ( ⁇ : no odor, good sweat absorption, good wearing feeling, ⁇ : slightly bad odor, sweat absorption, ordinary wearing feeling, X: strong odor, strong sweat absorption, poor wearing feeling) was performed. Table 2 shows the results.
- Test example 4 Dissolution test
- a dissolution test was performed by shaking 0.405 g of the sock section produced in Example 1 in 1 O ml of pure water at room temperature. Elution using HPLC As a result of analysis of the components thus obtained, elution of L-lysine of 0.094 mmOI and 0.0115 mmOI was observed after 1 hour and 5 hours after 1 g of the section. No eluate other than L-lysine was observed.
- a medical mask was prepared using the nonwoven fabric of L-lysine cellulose partial ester citrate of Production Example 1 and the nonwoven fabric of L-arginine cellulose partial ester citrate of Production Example 2, respectively.
- a medical mask was similarly prepared using unprocessed nonwoven fabric as a comparative product.
- the feeling of wearing these medical masks when wearing them was as follows: (1) Very bad feeling of use, (2) Poor feeling of use, (3) Normal, (4) Good feeling, (5) Very good feeling of use. Between a medical mask made using a nonwoven fabric of L-lysine cellulose partial ester citrate and a nonwoven fabric of L-arginine cellulose partial ester citrate, and a medical mask made using an unprocessed nonwoven fabric, There was no difference in the evaluation points.
- a 0.422 g section of a medical mask using a non-woven fabric of L-lysine cellulose partially ester citrate prepared in Example 2 was placed in 10 ml of water in a room. Dissolution tests were performed by shaking at warm. As a result of analysis of the eluted components using HPLC, it was confirmed that 0.001 mmol of L-lysine was released after 1 hour and 0.0130 mmol of I-lysine after 5 hours per 1 g of the section. No eluate other than L-lysine was observed.
- a cellulose fiber that has been made antibacterial by heat treatment after contacting with a basic amino acid ester is a cloth product having at least one effect of being excellent in antibacterial properties, deodorant properties, durability against washing, and safety. It can now be provided. Since the fabric product has excellent antibacterial properties and safety, it is particularly suitably used as a medical or sanitary product.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Textile Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/296,217 US20040083556A1 (en) | 2000-05-30 | 2001-05-29 | Fiber product having antibacterial and deodorant function |
| EP01932316A EP1291460A4 (en) | 2000-05-30 | 2001-05-29 | FIBROUS PRODUCT HAVING AN ANTIBACTERIAL AND DEODORIZING FUNCTION |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000159774A JP2001340378A (ja) | 2000-05-30 | 2000-05-30 | 医療または衛生用品 |
| JP2000-159774 | 2000-05-30 | ||
| JP2000-251070 | 2000-08-22 | ||
| JP2000251070A JP2002069843A (ja) | 2000-08-22 | 2000-08-22 | 抗菌、防臭機能を有する布製品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001092632A1 true WO2001092632A1 (en) | 2001-12-06 |
Family
ID=26592880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2001/004493 Ceased WO2001092632A1 (en) | 2000-05-30 | 2001-05-29 | Fiber product having antibacterial and deodorant function |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1291460A4 (ja) |
| KR (1) | KR20030005433A (ja) |
| CN (1) | CN1432085A (ja) |
| WO (1) | WO2001092632A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003041516A1 (fr) * | 2001-11-16 | 2003-05-22 | Ajinomoto Co., Inc. | Matieres d'emballage antibacteriennes |
| WO2004062703A1 (en) * | 2003-01-15 | 2004-07-29 | Sca Hygiene Products Ab | Bacteria trapping fibrous material |
| US7985209B2 (en) | 2005-12-15 | 2011-07-26 | Kimberly-Clark Worldwide, Inc. | Wound or surgical dressing |
| US8871232B2 (en) | 2007-12-13 | 2014-10-28 | Kimberly-Clark Worldwide, Inc. | Self-indicating wipe for removing bacteria from a surface |
| JP2021516731A (ja) * | 2018-03-19 | 2021-07-08 | リヴィンガード エージー | 抗菌有機布地 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040166144A1 (en) | 2003-01-15 | 2004-08-26 | Arie Besemer | Bacteria trapping fibrous material |
| EP1978140B1 (en) | 2007-04-04 | 2014-08-13 | The Procter & Gamble Company | Material for acquisition of liquids and disposable absorbent article comprising the material |
| CN102899895A (zh) * | 2012-09-26 | 2013-01-30 | 泰安市金飞虹织造有限公司 | 一种纤维素面料抗菌除臭的处理方法 |
| CA2905788C (en) * | 2013-03-12 | 2022-08-16 | Emily A. Stein | Dental composition comprising chelator and base |
| CN104264486B (zh) * | 2014-09-22 | 2017-04-05 | 杭州诺邦无纺股份有限公司 | ε‑聚赖氨酸协同仿生酶整理方法 |
| CN104383586B (zh) * | 2014-12-01 | 2016-05-11 | 哈尔滨工业大学 | 一种纳米金/赖氨酸/氧化再生纤维素复合止血材料及其制备方法 |
| CN111954733A (zh) * | 2018-03-19 | 2020-11-17 | 生活保卫股份公司 | 有机抗菌纺织品 |
| KR102048212B1 (ko) | 2018-06-05 | 2019-11-25 | 문정심 | 보온 통풍성과 미끄럼 방지 기능이 향상된 스타킹 |
| CN109847455B (zh) * | 2019-01-29 | 2021-07-06 | 四川大学 | 一种过滤细微颗粒物的复合材料、其制备方法及应用 |
| US12209344B2 (en) | 2020-08-31 | 2025-01-28 | Nano And Advanced Materials Institute Limited | Bactericidal and virucidal fabric |
| US11856953B2 (en) | 2021-03-11 | 2024-01-02 | Nano And Advanced Materials Institute Limited | Launderable bactericidal and virucidal fabric finish |
| CN113249966B (zh) * | 2021-06-07 | 2023-01-24 | 浙江理工大学 | 一种洗涤增强抗菌性能的抑菌棉布 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4077771A (en) * | 1975-07-16 | 1978-03-07 | Toyo Boseki Kabushiki Kaisha | Process for treating fibrous material |
| JPH03199470A (ja) * | 1989-12-26 | 1991-08-30 | Ajinomoto Co Inc | セルロース系繊維の改質方法 |
| JPH09132869A (ja) * | 1995-09-06 | 1997-05-20 | Chisso Corp | 抗菌性繊維及びそれを用いた繊維製品 |
| JPH11113780A (ja) * | 1997-10-14 | 1999-04-27 | Asahi Chem Ind Co Ltd | 除菌ウェットティッシュ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2131404A1 (de) * | 1971-06-24 | 1972-12-28 | Ajinomoto Kk | Bakterizide,germizide und antiseptische Mittel |
| US3728213A (en) * | 1971-08-18 | 1973-04-17 | American Cyanamid Co | Antibiotic paper |
| US5104649A (en) * | 1988-05-11 | 1992-04-14 | Monsanto Company | Surface-functionalized biocidal polymers |
| IL113534A0 (en) * | 1995-04-28 | 1995-07-31 | Shenkar College Textile Tech | Microbistatic and deodorizing of cellulose fibers |
| JP3051709B2 (ja) * | 1997-09-30 | 2000-06-12 | 憲司 中村 | 抗菌性セルロ−ス繊維及びその製造方法 |
-
2001
- 2001-05-29 EP EP01932316A patent/EP1291460A4/en not_active Withdrawn
- 2001-05-29 CN CN01810541A patent/CN1432085A/zh active Pending
- 2001-05-29 WO PCT/JP2001/004493 patent/WO2001092632A1/ja not_active Ceased
- 2001-05-29 KR KR1020027016238A patent/KR20030005433A/ko not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4077771A (en) * | 1975-07-16 | 1978-03-07 | Toyo Boseki Kabushiki Kaisha | Process for treating fibrous material |
| JPH03199470A (ja) * | 1989-12-26 | 1991-08-30 | Ajinomoto Co Inc | セルロース系繊維の改質方法 |
| JPH09132869A (ja) * | 1995-09-06 | 1997-05-20 | Chisso Corp | 抗菌性繊維及びそれを用いた繊維製品 |
| JPH11113780A (ja) * | 1997-10-14 | 1999-04-27 | Asahi Chem Ind Co Ltd | 除菌ウェットティッシュ |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP1291460A4 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003041516A1 (fr) * | 2001-11-16 | 2003-05-22 | Ajinomoto Co., Inc. | Matieres d'emballage antibacteriennes |
| WO2004062703A1 (en) * | 2003-01-15 | 2004-07-29 | Sca Hygiene Products Ab | Bacteria trapping fibrous material |
| US7985209B2 (en) | 2005-12-15 | 2011-07-26 | Kimberly-Clark Worldwide, Inc. | Wound or surgical dressing |
| US8871232B2 (en) | 2007-12-13 | 2014-10-28 | Kimberly-Clark Worldwide, Inc. | Self-indicating wipe for removing bacteria from a surface |
| JP2021516731A (ja) * | 2018-03-19 | 2021-07-08 | リヴィンガード エージー | 抗菌有機布地 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1291460A4 (en) | 2004-03-31 |
| KR20030005433A (ko) | 2003-01-17 |
| EP1291460A1 (en) | 2003-03-12 |
| CN1432085A (zh) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6612375B6 (ja) | 布地及び関連する基材のための消毒性組成物、及び抗菌的、抗ウイルス的、及び抗真菌的消毒性、洗浄耐久性を提供し、多機能的特性を用いて必要に応じて強化するための基材の処理方法 | |
| WO2001092632A1 (en) | Fiber product having antibacterial and deodorant function | |
| KR101004280B1 (ko) | 항균성 섬유 및 그 제조 방법 그리고 항균성 섬유를 함유하여 이루어지는 항균성 섬유 제품, 그 제조 방법 및 재생 방법 | |
| US6077319A (en) | Processes for preparing microbiocidal textiles | |
| US5856248A (en) | Microbistatic and deodorizing cellulose fibers | |
| JP4705778B2 (ja) | カルボキシメチル化セルロース創傷用包帯 | |
| JPH0931847A (ja) | 機能性繊維製品およびその製造方法 | |
| CN101225604A (zh) | 一种含抗菌肽的涂层织物及其制备方法 | |
| RU2145880C1 (ru) | Медицинский текстильный материал с антимикробным и вирулицидным действием и изделия из него | |
| Gokarneshan et al. | Developments in antimicrobial textiles-some insights on current research trends | |
| US20040083556A1 (en) | Fiber product having antibacterial and deodorant function | |
| WO2003041516A1 (fr) | Matieres d'emballage antibacteriennes | |
| JP4043967B2 (ja) | 機能性繊維製品 | |
| JP2000328469A (ja) | 機能性ナイロン系繊維製品の製造法 | |
| JP4911398B2 (ja) | 包帯 | |
| JP2003310721A (ja) | 竹繊維製抗菌性布帛 | |
| JPH08119805A (ja) | 抗菌性多孔質材料 | |
| CN101003943A (zh) | 钠米抗菌棉纺织材料及其系列卫生日用品 | |
| CN1090904C (zh) | 高效广谱杀菌剂及利用其制备卫生杀菌用品的方法 | |
| JP2002069843A (ja) | 抗菌、防臭機能を有する布製品 | |
| Lakshmi¹ et al. | A COMPARATIVE STUDY ON THE ANTIMICROBIAL PROPERTIES OF SERICIN AND FISH SCALE COLLAGEN APPLIED ON VISCOSE RAYON FABRIC | |
| JP2578514Y2 (ja) | 靴 下 | |
| KR100828023B1 (ko) | 섬유유연제 조성물 | |
| EP4151797A1 (en) | Antimicrobial textiles with adhered polycationic polymers and subjected to an acid treatment | |
| TR202012284A2 (tr) | Birden fazla fonksiyonel özelliği yapısında bulunduran tek katmanlı havlu kumaş |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN KR US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2001932316 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020027016238 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 018105416 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020027016238 Country of ref document: KR |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001932316 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10296217 Country of ref document: US |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2001932316 Country of ref document: EP |


